Zinc finger and BTB domain-containing protein 9 (ZBTB9)

Zinc finger and BTB domain-containing protein 9 (ZBTB9) is a transcription factor characterized by the presence of both zinc finger motifs and a BTB (POZ) domain, conferring DNA binding and protein-protein interaction capabilities. It is predicted to regulate gene expression via RNA polymerase II and is mainly localized to the nucleus[4][5]. ZBTB9 is overexpressed in a range of cancers, most notably liver hepatocellular carcinoma, where its upregulation correlates with increased tumor grade, stage, and poor prognosis[2]. Mechanistically, it may drive tumorigenesis through the activation of cell cycle, DNA repair, MYC, and KRAS-related pathways, as well as contributing to immune evasion in the tumor microenvironment[2]. Knockdown experiments suggest that ZBTB9 promotes tumor cell proliferation and migration. It therefore represents a potential therapeutic target and prognostic biomarker in oncology, although direct drugs or inhibitors are not yet documented.

Other names

MGC23166ZNF919zinc finger and BTB domain containing 9ZBTB9

No direct drug mechanisms currently established; potential for targeting transcriptional regulation or co-repressor recruitment in oncology